Although the best-known effect of glucagon is an increase in blood glucose concentration, early preparations of glucagon were contaminated by a considerable amounts of insulin. This led to the reinvestigation of the degree and duration of the hyperglycemic response using a recent glucagon preparation which contained very little insulin (5mU/mg), since it is useful to know the intensity and duration of the response. On the other hand, glucagon has been shown to have effects on lipid metabolism and adipose tissue, although little is known about the influence of glucagon on the cholesterol and triglyceride concentrations in blood. Since the etiological significance of cholesterol and triglyceride in arteriosclerosis, diabetes mellitus and related diseases has been discussed, it is interesting to know the effect of this hormone on these lipids.
Glucagon (Lilly), 1mg dissolved in 20m
l of physiological saline, was injected intravenously into 16 normal nonobese controls (N) and 32 untreated nonobese diabetics. The diabetics were classified as D
1 (11 cases, fasting blood glucose under 129 mg%), D
2 (12 cases, fasting blood glucose 130-199mg%) and D
3 (12 cases, fasting blood glucose>200 mg%).
1. Peak values of blood glucose concentration were obtained after 15-30 minutes in N, after 30 minutes D
1 and D
2, after 45 minutes in D
3.
2. The mean maximum increment in blood glucose was 44±4.3 mg/dl (mean +SEM) in N, 57±6.6 mg/d
l in D
1, 80±5.6 mg/d
l in D
2 and 78±12.3 mg/d
l in D
3.
3. Blood glucose returned to basal level 60 minutes after the injection in N, 90 minutes after the injection in D
1, 90-120 minutes in D
2 and 120 minutes after the injection in D
3. These results suggest that the glucagon tolerance test reflects fairly well the severity of diabetes.
4. Blood cholesterol concentration showed no change or showed a very slight and transient decrease (0.9%-1.37%) after glucagon injection, but glucagon induced a meaningful decrease (p<0.005) in triglyceride concentration both in controls and diabetics. Mean fasting levels of triglyceride are 106±15.5 mg/d
l in N, 95±12.2 mg/d
l in D
1, 136±16.0 mg/l in D
2 and 153±26.6 mg/d
l in D
3. The mean maximum decrease are 16.8% in N, 17.7% in D
2 and 24% in D
3120min. after injection. In D
1, however, the change was shown to be not constant. The mean maximum change is only -5.3% at 60min.
The effect of glucagon on plasma lipid was discussed.
View full abstract